Skip to main content
Premium Trial:

Request an Annual Quote

Flanders Gov't Awards Galapagos $1.6M to Develop Drug-Discovery Models

NEW YORK (GenomeWeb News) - The Flanders government awarded €1.8 million ($1.6 million) to Galapagos for a two-year program to develop biological models for drug discovery.
 
Galapagos will develop in vitro cellular models, in vivo animal models, and ex vivo human models to evaluate the effectiveness of small molecules to treat rheumatoid arthritis and osteoporosis. 
 
As part of the grant, Galapagos will collaborate with the University of Antwerp, the University of Ghent, and the Flanders Inter-University Institute for Biotechnology.
 
The Institute for the Promotion of Innovation by Science and Technology made the award.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.